Related Experiment Video
Updated: Jun 5, 2026

11:06
Identifying DNA Mutations in Purified Hematopoietic Stem/Progenitor Cells
Published on: February 24, 2014
Mouse DNA contamination in human tissue tested for XMRV
Mark J Robinson1, Otto W Erlwein, Steve Kaye
1Section of Infectious Diseases, Jefferiss Research Trust Laboratories, Imperial College London, St Mary's Campus, London, W2 1PG, UK.
Retrovirology
|December 22, 2010
Summary
Xenotropic murine leukemia virus-related virus (XMRV) detection in prostate cancer was investigated. Results indicate widespread mouse DNA contamination in laboratory samples, challenging previous findings.
Area of Science:
- Virology
- Oncology
- Molecular Biology
Background:
- Xenotropic murine leukemia virus-related virus (XMRV) association with human diseases, including prostate cancer, is controversial.
- Previous XMRV identification in US patients contrasts with limited European findings.
- Concerns exist regarding sample contamination in retroviral studies.
Purpose of the Study:
- To investigate the prevalence of XMRV genetic sequences in human prostate cancer tissues.
- To assess the extent of mouse DNA contamination in these samples using sensitive assays.
Main Methods:
- PCR-based detection of XMRV sequences in formalin-fixed paraffin-embedded prostate tissues.
- Control assays for mouse mitochondrial DNA (mtDNA) and intracisternal A particle (IAP) DNA to detect contamination.
- Analysis of XMRV, IAP, and mtDNA sequences in prostate cancer samples.
Main Results:
- XMRV-like sequences were detected in 4.8% of prostate cancers, aligning with US prevalence.
- A significant percentage of samples, including XMRV-negative ones, tested positive for IAP sequences (21.5%).
- Many samples also showed positivity for mouse mtDNA, indicating widespread contamination.
Conclusions:
- Mouse DNA contamination is prevalent in laboratory specimens and detectable by sensitive assays like IAP PCR.
- Less sensitive assays, such as murine mtDNA PCR, may not reliably detect contamination.
- This study emphasizes the need for rigorous validation to prevent false associations between murine retroviruses and human diseases.

